Skip to main content

News All News

Press Contact: Kirsten Mabry | (617) 495-4157

Tag: Hms

December 16th, 2015

No sharks in these waters

Two emerging life-science ventures draw a crowd and elicit substantive expert feedback at “Guppy Tank” event.

Guppytank13 400sq

July 15th, 2013

Ipsen announce a sponsored research agreement with Harvard Medical School to discover novel engineered botulinum toxins for serious neurologic diseases

Paris (France), 15 July 2013 - Ipsen (Euronext: IPN, ADR: IPSEY) announced today that it
has initiated a research and development collaboration on novel engineered botulinum toxins
with Harvard Medical School (Harvard).

Under the terms of the agreement, Ipsen will fund Harvard research for at least three years
with the aim to discover, evaluate and develop novel engineered recombinant botulinum
toxins for the treatment of serious neurologic diseases.

Page 1 of 1